Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion type Assertion NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_head.
- NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion description "[High BCL2 levels have been detected in most human lymphoid malignancies, not limited to follicular lymphoma (where the role of BCL2 overexpression is driven by the t[14;18] translocation) but also B-cell chronic lymphocytic leukemia (CLL) and multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_provenance.
- NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion evidence source_evidence_literature NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_provenance.
- NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion SIO_000772 24095849 NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_provenance.
- NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion wasDerivedFrom befree-20150227 NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_provenance.
- NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_assertion wasGeneratedBy ECO_0000203 NP262498.RAwQ5sKyar1y26JvLmEePrm8eOKDAj7wQycWmNsqyBzt4130_provenance.